<DOC>
	<DOCNO>NCT01960803</DOCNO>
	<brief_summary>The overall objective study determine feasibility tolerability single dose Intraoperative Electron Radiation Treatment ( `` IOERT '' ) definitive therapy administer time breast conserve surgery patient early stage breast cancer .</brief_summary>
	<brief_title>Lumpectomy Followed By Intraoperative Electron Radiation Therapy ( IOERT )</brief_title>
	<detailed_description>Evaluate local distant recurrence rate cosmetic outcome . Both clinical evaluation cosmetic outcome Surgeon , subjective impression cosmetic outcome patient , evaluate use questionnaire . Local recurrence evaluate image protocol use Whole breast radiation .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Ductal , Breast</mesh_term>
	<criteria>Patient agree breast conservation therapy ( segmental resection , partial mastectomy , radiation therapy ) treatment breast cancer Patient agree evaluation axilla sentinel lymph node biopsy Postmenopausal woman age &gt; 60 , define woman experience menstrual period past 6 month BRCA1 2 gene mutation negative , test . [ genetic test NOT require base upon personal family history ] Unifocal ( unicentric ) , invasive ductal carcinoma favorable subtypes ( mucinous , tubular , colloid ) &lt; 2.0 cm diameter , primary Tstage T1 ( AJCC criterion ) Grade 1 , 2 , 3 acceptable Associated LCIS allow Estrogen receptor ( ER ) status positive Patient clear margin &gt; 2 mm gross pathologic examination Patient nodenegative , define N0 ( ) N0 ( i+ ) Patient must deem functionally mentally competent understand sign inform consent Prior breast malignancy malignancy metastatic , expect survival &lt; 5 year Immunocompromised status Pregnancy Women active connective tissue disorder ( i.e . scleroderma , lupus others ) Breast cancer involve skin chest wall , locally advanced breast cancer Pure DCIS , grade Invasive lobular carcinoma Evidence lymphovascular invasion ( LVI ) Invasive carcinoma extensive intraductal component ( EIC ) Neoadjuvant chemotherapy Patients 1 positive lymph node determine surgery sentinel node and/or axillary dissection Someone candidate breast conserve management , i.e. , prior whole breast radiation therapy</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Stage I Breast Carcinoma</keyword>
</DOC>